tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Immutep Director Increases Stake Through Performance Rights Exercise
Company AnnouncementsImmutep Director Increases Stake Through Performance Rights Exercise
2d ago
Immutep Ltd Director Increases Shareholding Through Performance Rights Conversion
PremiumCompany Announcements
Immutep Ltd Director Increases Shareholding Through Performance Rights Conversion
2d ago
Immutep Ltd Issues 4.8 Million New Securities on ASX
PremiumCompany Announcements
Immutep Ltd Issues 4.8 Million New Securities on ASX
7d ago
Immutep to Engage in Key Investor Conferences
PremiumCompany Announcements
Immutep to Engage in Key Investor Conferences
9d ago
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
PremiumRatings
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
14d ago
IMMP
Immutep announces first patient dosed in TACTI-004 Phase III trial
PremiumThe FlyImmutep announces first patient dosed in TACTI-004 Phase III trial
16d ago
IMMP
Immutep Doses First Patient in Pivotal Phase III Lung Cancer Trial
Premium
Company Announcements
Immutep Doses First Patient in Pivotal Phase III Lung Cancer Trial
16d ago
Immutep announces poster presentation for the TACTI-004 Phase III trial
Premium
The Fly
Immutep announces poster presentation for the TACTI-004 Phase III trial
21d ago
MRK
IMMP
Immutep to Present Pivotal Lung Cancer Trial at ELCC 2025
PremiumCompany Announcements
Immutep to Present Pivotal Lung Cancer Trial at ELCC 2025
21d ago
Immutep Ltd Reports Increased Income Amid Rising R&D Costs
PremiumCompany Announcements
Immutep Ltd Reports Increased Income Amid Rising R&D Costs
1M ago
Immutep Reports Increased Revenue but Higher Losses Amid R&D Investments
PremiumCompany Announcements
Immutep Reports Increased Revenue but Higher Losses Amid R&D Investments
1M ago
Immutep Limited Reports Cessation of Securities
PremiumCompany Announcements
Immutep Limited Reports Cessation of Securities
2M ago
Immutep Ltd Updates Stakeholders on Business Progress
PremiumCompany AnnouncementsImmutep Ltd Updates Stakeholders on Business Progress
2M ago
Immutep promotes Christian Mueller to CDO, CMO Florian Vogl to depart
Premium
The Fly
Immutep promotes Christian Mueller to CDO, CMO Florian Vogl to depart
2M ago
IMMP
Immutep reports Q2 cash receipts from customers A$8,000
Premium
The Fly
Immutep reports Q2 cash receipts from customers A$8,000
2M ago
IMMP
Immutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
PremiumThe Fly
Immutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
3M ago
IMMP
Immutep Completes Patient Enrolment for Key Phase II Cancer Trial
PremiumCompany Announcements
Immutep Completes Patient Enrolment for Key Phase II Cancer Trial
3M ago
Immutep completes patient enrollment for INSIGHT-003
PremiumThe Fly
Immutep completes patient enrollment for INSIGHT-003
3M ago
IMMP
Immutep Completes Enrolment for Promising INSIGHT-003 Cancer Trial
PremiumCompany Announcements
Immutep Completes Enrolment for Promising INSIGHT-003 Cancer Trial
3M ago
Immutep announces initial safety data from Phase I study on IMP761
PremiumThe FlyImmutep announces initial safety data from Phase I study on IMP761
4M ago
IMMP
Immutep Ltd Announces Cessation of Performance Rights
Premium
Company Announcements
Immutep Ltd Announces Cessation of Performance Rights
4M ago
Immutep Reveals Promising Data for IMP761 Trial
Premium
Company Announcements
Immutep Reveals Promising Data for IMP761 Trial
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >